AGP Picks
View all

Healthy Living Europe
Provided by AGP

Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

Press releases published on September 15, 2026

Clene Announces $4 Million Registered Direct Offering
Sep. 15, 2026

Clene Announces $4 Million Registered Direct Offering

Indeterminate GlobeNewswire
MitoRx Therapeutics Appoints Clinical & Scientific Advisory Board to Guide the Development of MTRX31
Sep. 15, 2026

MitoRx Therapeutics Appoints Clinical & Scientific Advisory Board to Guide the Development of MTRX31

Indeterminate GlobeNewswire
Tria Federal Achieves CMMC Level 2 Certification, Affirming Its Ability to Protect Sensitive Federal Data
Sep. 15, 2026

Tria Federal Achieves CMMC Level 2 Certification, Affirming Its Ability to Protect Sensitive Federal Data

Indeterminate GlobeNewswire
PRM Expands Advanced Endometriosis Care in Falls Church with Gynecologic Surgeon Dr. Anna Reinert
Sep. 15, 2026

PRM Expands Advanced Endometriosis Care in Falls Church with Gynecologic Surgeon Dr. Anna Reinert

Indeterminate GlobeNewswire
Avaí Bio and Austrianova Complete Adventitious Agent Testing of Master Cell Bank, Establish Working Cell Bank for α-Klotho Anti-Aging Therapy
Sep. 15, 2026

Avaí Bio and Austrianova Complete Adventitious Agent Testing of Master Cell Bank, Establish Working Cell Bank for α-Klotho Anti-Aging Therapy

Indeterminate GlobeNewswire
Ernexa Therapeutics Reports Positive Disease Modifying ERNA-201 Preclinical Data, Reinforcing iMSC Platform as Company Accelerates Oncology Strategy and ERNA-101 Toward First-in-Human Dosing
Sep. 15, 2026

Ernexa Therapeutics Reports Positive Disease Modifying ERNA-201 Preclinical Data, Reinforcing iMSC Platform as Company Accelerates Oncology Strategy and ERNA-101 Toward First-in-Human Dosing

Indeterminate GlobeNewswire
Sienna Announces September Dividend
Sep. 15, 2026

Sienna Announces September Dividend

Indeterminate GlobeNewswire
PolyPid Announces Participation in Upcoming Fall Investor Conferences
Sep. 15, 2026

PolyPid Announces Participation in Upcoming Fall Investor Conferences

Indeterminate GlobeNewswire
Dimenso Raises $650,000 to Bring Physical AI and Smart Glasses to Life Sciences Laboratories
Sep. 15, 2026

Dimenso Raises $650,000 to Bring Physical AI and Smart Glasses to Life Sciences Laboratories

Indeterminate GlobeNewswire
Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics
Sep. 15, 2026

Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics

Indeterminate GlobeNewswire
MAIA Biotechnology Announces Open Market Purchases of Company Stock by Long-Standing Board Member and CEO
Sep. 15, 2026

MAIA Biotechnology Announces Open Market Purchases of Company Stock by Long-Standing Board Member and CEO

Indeterminate GlobeNewswire
NKGen Biotech to Present on Troculeucel for Neurodegenerative Diseases at 4th Great Bay Cell and Gene Therapy Forum
Sep. 15, 2026

NKGen Biotech to Present on Troculeucel for Neurodegenerative Diseases at 4th Great Bay Cell and Gene Therapy Forum

Indeterminate GlobeNewswire
Azalea Health Selected by East Adams Rural Healthcare to Modernize EHR Operations
Sep. 15, 2026

Azalea Health Selected by East Adams Rural Healthcare to Modernize EHR Operations

Indeterminate GlobeNewswire
Oxford Brain Diagnostics Appoints Healthcare AI Executive Jieun Choe as Chief Executive Officer and Board Director
Sep. 15, 2026

Oxford Brain Diagnostics Appoints Healthcare AI Executive Jieun Choe as Chief Executive Officer and Board Director

Indeterminate GlobeNewswire
Biodexa Enters Into Warrant Exercise Transaction for $2.3 Million in Gross Proceeds
Sep. 15, 2026

Biodexa Enters Into Warrant Exercise Transaction for $2.3 Million in Gross Proceeds

Indeterminate GlobeNewswire
LB Pharmaceuticals Appoints Susan G. Kozauer, M.D. as Chief Medical Officer
Sep. 15, 2026

LB Pharmaceuticals Appoints Susan G. Kozauer, M.D. as Chief Medical Officer

Indeterminate GlobeNewswire
Allarity Therapeutics Granted Japanese Patent for Stenoparib DRP® Companion Diagnostic, Further Strengthening Stenoparib Development
Sep. 15, 2026

Allarity Therapeutics Granted Japanese Patent for Stenoparib DRP® Companion Diagnostic, Further Strengthening Stenoparib Development

Indeterminate GlobeNewswire
MEDIA ADVISORY: New Report Tracking Under-Used Hospitals, Deficits, Cuts & Inequities in Health Care Across Ontario
Sep. 15, 2026

MEDIA ADVISORY: New Report Tracking Under-Used Hospitals, Deficits, Cuts & Inequities in Health Care Across Ontario

Indeterminate GlobeNewswire
Peer-Reviewed Study of Lifeward’s ReWalk® Exoskeleton Reports Significant Improvements in Daily Activity Performance, Satisfaction, and Pain
Sep. 15, 2026

Peer-Reviewed Study of Lifeward’s ReWalk® Exoskeleton Reports Significant Improvements in Daily Activity Performance, Satisfaction, and Pain

Indeterminate GlobeNewswire
Addgene Launches Transfection-Ready DNA Service to Accelerate Academic and Industry Research
Sep. 15, 2026

Addgene Launches Transfection-Ready DNA Service to Accelerate Academic and Industry Research

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthy Living Europe

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.